Xvivo Perfusion AB (publ) (STO: XVIVO)
Sweden
· Delayed Price · Currency is SEK 533.00
+3.00 (0.57%)
Aug 30, 2024, 5:29 PM CET
Xvivo Perfusion AB Employees
Xvivo Perfusion AB had 160 employees as of December 31, 2023. The number of employees increased by 20 or 14.29% compared to the previous year.
Employees
160
Change (1Y)
20
Growth (1Y)
14.29%
Revenue / Employee
4.60M SEK
Profits / Employee
794.32K SEK
Market Cap
16.79B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 160 | 20 | 14.29% |
| Dec 31, 2022 | 140 | 27 | 23.89% |
| Dec 31, 2021 | 113 | 31 | 37.80% |
| Dec 31, 2020 | 82 | 42 | 105.00% |
| Dec 31, 2018 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca PLC | 89,900 |
| Swedish Orphan Biovitrum AB (publ) | 1,772 |
| Getinge AB (publ) | 11,891 |
| Sectra AB (publ) | 1,204 |
| Camurus AB (publ) | 213 |
| Medicover AB (publ) | 45,316 |
| Elekta AB (publ) | 4,718 |
| AddLife AB (publ) | 2,301 |